-
PTC299 is a dual and orally active DHODH and VEGF inhibitor, has broad and potent activity against hematological cancer cells.
Categories
Others
Archives
- June 2019 (1)
Thanks, your subscription has been confirmed. You will hear from us soon.
Submission failed, please try again later.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.